Latest AERI News

• United Therapeutics (UTHR) Initiates Tyvaso Study in IPF - Zacks Investment Research - Wed, Oct 12, 2022 4:14 PM
• Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why - Zacks Investment Research - Mon, Oct 10, 2022 3:23 PM
• GSK's (GSK) Boostrix Gets FDA Nod for Pertussis in Newborns - Zacks Investment Research - Mon, Oct 10, 2022 3:21 PM
• ImmunoGen (IMGN) Q3 Loss Wider, Sales Beat, '22 View Up - Zacks Investment Research - Mon, Nov 7, 2022 7:07 PM
• Zoetis' (ZTS) Lags Q3 Earnings Estimates, Lowers 2022 Guidance - Zacks Investment Research - Thu, Nov 3, 2022 5:34 PM
• The Zacks Analyst Blog Highlights SilverBow Resources, Amalgamated Financial, PHX Minerals, Richardson Electronics and Aerie Pharmaceuticals - Zacks Investment Research - Mon, Oct 24, 2022 1:30 PM
• Talaris (TALS) Down on Patient Death From Renal Transplant Study - Zacks Investment Research - Fri, Oct 21, 2022 3:28 PM
• Add These 4 Top-Ranked Liquid Stocks For Healthy Gains - Zacks Investment Research - Fri, Oct 21, 2022 12:50 PM
• 5 Small Hidden Gems Flying High Despite Market's Bloodbath - Zacks Investment Research - Fri, Oct 21, 2022 12:17 PM
• Zacks Industry Outlook Highlights Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and Fusion Therapeutics - Zacks Investment Research - Fri, Oct 21, 2022 9:35 AM